En | De
Sie sind hier: Respirationstrakt » Neoplasie 20. Oktober 2020
Erweiterte Suche
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Allergische Rhinitis - Pollinosis
Interstitielle Pneumopathien
Schlaf- Apnoe-Syndrom
Zystische Fibrose
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 5535  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 110691  
Genetic variants as predictors of toxicity and response in patients with non-small cell lung cancer undergoing first-line platinum-based chemotherapy: Design of the multicenter PGxLUNG study.
Thorac Cancer
de Jong C, Herder GJM, Deneer VHM.
PMID: 33073546 [PubMed - as supplied by publisher]

Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study.
Thorac Cancer
Ai B, Zhang L, Huang D, Chen J, Liu Z, Hu X, Zhou S, Hu Y, Zhao J, Yang F.
PMID: 33073527 [PubMed - as supplied by publisher]

CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer.
Clin Transl Radiat Oncol
Walls GM, Oughton JB, Chalmers AJ, Brown S, Collinson F, Forster MD, Franks KN, Gilbert A, Hanna GG, Hannaway N, Harrow S, Haswell T, Hiley CT, Hinsley S, Krebs M, Murden G, Phillip R, Ryan AJ, Salem A, Sebag-Montefoire D, Shaw P, Twelves CJ, Walker K, Young RJ, Faivre-Finn C, Greystoke A.
PMID: 33072895 [PubMed]

SABR-BRIDGE: Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts During the COVID-19 Pandemic.
Front Oncol
Kidane B, Spicer J, Kim JO, Fiset PO, Abdulkarim B, Malthaner R, Palma D.
PMID: 33072612 [PubMed]

A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS-Mutant Advanced Lung Adenocarcinoma.
Front Oncol
Xiang L, Fu X, Wang X, Li W, Zheng X, Nan K, Tian T.
PMID: 33072585 [PubMed]

Clinical Efficacy of Immune Checkpoint Inhibitors in Older Non-small-Cell Lung Cancer Patients: A Meta-Analysis.
Front Oncol
Sun YM, Wang Y, Sun XX, Chen J, Gong ZP, Meng HY.
PMID: 33072584 [PubMed]

Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer.
Front Oncol
Su C, Wang H, Liu Y, Guo Q, Zhang L, Li J, Zhou W, Yan Y, Zhou X, Zhang J.
PMID: 33072580 [PubMed]

Exosome-Derived LncRNAs in Lung Cancer.
Front Oncol
Fan T, Sun N, He J.
PMID: 33072553 [PubMed]

Impact of Age on the Efficacy of Immune Checkpoint Inhibitor-Based Combination Therapy for Non-small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Front Oncol
Yan X, Tian X, Wu Z, Han W.
PMID: 33072551 [PubMed]

The Change Trend of Cause of Death in Patients With Stage I Non-Small Cell Lung Cancer After Surgery in US: A Long-Term Follow-Up Study Based on SEER Database.
Cancer Control
Peng WD, Xie J, Zhang X, Li C.
PMID: 33070629 [PubMed - in process]

Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL).
Lung Cancer
Garcia-Campelo R, Arrieta O, Massuti B, Rodriguez-Abreu D, Granados ALO, Majem M, Vicente D, Lianes P, Bosch-Barrera J, Insa A, Dómine M, Reguart N, Guirado M, Sala MÁ, Vázquez-Estevez S, Caro RB, Drozdowskyj A, Verdú A, Karachaliou N, Molina-Vila MA, Rosell R, Spanish Lung Cancer Group (SLCG)..
PMID: 33070053 [PubMed - as supplied by publisher]

Brief Report: Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer.
J Thorac Oncol
Awad MM, Gadgeel SM, Borghaei H, Patnaik A, Chih-Hsin Yang J, Powell SF, Gentzler RD, Martins RG, Stevenson JP, Altan M, Jalal SI, Panwalkar A, Gubens M, Sequist LV, Saraf S, Zhao B, Piperdi B, Langer CJ.
PMID: 33069888 [PubMed - as supplied by publisher]

COV is a readily available quantitative indicator of metabolic heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer.
Eur J Radiol
Yu T.
PMID: 33068840 [PubMed - as supplied by publisher]

A Lung Cancer Patient with Dyspnea: Diagnostic Difficulties during the COVID-19 Pandemic.
Cancer Cell
Pruis MA, Hussain B, Bakker M, Hoek RAS, Miedema JR, Dingemans AC, Paats MS.
PMID: 33068525 [PubMed - as supplied by publisher]

Why And When To Request For A Pet/Ct Scan In A Lung Cancer Patient?
Rev Port Cir Cardiotorac Vasc
Colarinha P.
PMID: 33068505 [PubMed - in process]

Understanding EGFR heterogeneity in lung cancer.
Passaro A, Malapelle U, Del Re M, Attili I, Russo A, Guerini-Rocco E, Fumagalli C, Pisapia P, Pepe F, De Luca C, Cucchiara F, Troncone G, Danesi R, Spaggiari L, De Marinis F, Rolfo C.
PMID: 33067323 [PubMed - in process]

Role of Antiangiogenic Agents Combined With EGFR Tyrosine Kinase Inhibitors in Treatment-naive Lung Cancer: A Meta-Analysis.
Clin Lung Cancer
Deng Z, Qin Y, Liu Y, Zhang Y, Lu Y.
PMID: 33067126 [PubMed - as supplied by publisher]

From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy.
Cancers (Basel)
Sesma A, Pardo J, Cruellas M, Gálvez EM, Gascón M, Isla D, Martínez-Lostao L, Ocáriz M, Paño JR, Quílez E, Ramírez A, Torres-Ramón I, Yubero A, Zapata M, Lastra R.
PMID: 33066479 [PubMed]

High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor Therapy.
Cancers (Basel)
Riemann D, Schütte W, Turzer S, Seliger B, Möller M.
PMID: 33066260 [PubMed]

The association study between CYP24A1 gene polymorphisms and risk of liver, lung and gastric cancer in a Chinese population.
Pathol Res Pract
Xiong Q, Jiao Y, Yang P, Liao Y, Gu X, Hu F, Chen B.
PMID: 33065483 [PubMed - as supplied by publisher]

   Artikel 1 - 20 / 110691    Seite 1 von 5535  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer





Haben Sie Ihr Passwort vergessen?


Neu bei My Medline?

Melden Sie sich bei My Medline an!


Mehr über My Medline erfahren

mehr >>


Sky right 1